Health Insurance Report™ helps you track and analyze legal, legislative, and regulatory developments affecting the health-insurance industry throughout implementation of the Affordable Care Act...
The Centers for Medicare & Medicaid Services said Sept. 19 that average Medicare Advantage premiums will remain steady in 2013 and that enrollment will climb.
Average monthly premiums for MA plans will increase by 4.7 percent, up from $31.12 in 2012 to $32.59 in 2013, CMS said. Enrollment is projected to grow 11 percent in 2013.
Despite the slight hike in next year's premiums, between 2011-2013, the average premium fell by 10 percent, Jonathan D. Blum, deputy administrator and director of CMS's Center for Medicare, said during a teleconference.
Over the same three-year period, he projected that the “number of beneficiaries choosing Part C” (Medicare managed care) would increase by 28 percent.
The teleconference was held in conjunction with CMS's release of spreadsheets on the results of CMS's negotiations with plans since bids were submitted in June. The information on individual plans includes monthly premiums, coverage in the so-called Part D (drug benefit) doughnut hole, and drug deductibles.
Plans may begin to market on Oct. 1 and beneficiaries may enroll in plans from Oct. 15 to Dec. 7.
America's Health Insurance Plans, the major industry trade group, cautioned that, despite the “good news” about premiums and enrollment, “[w]e remain concerned that the benefits and coverage Medicare Advantage beneficiaries rely on today could be put at risk” as cuts under the Affordable Care Act are phased in, along with a new premium tax.
With a goal of placing payments to managed care plans on par with traditional Medicare, the health reform law established a new blended benchmark, which required CMS to rank counties from lowest to highest by average fee-for-service costs and divide them into four quartiles. The benchmarks, which are the maximum amount Medicare will pay per month for required benefits in an MA plan's benefit package, are multiplied by 95 percent, 107.5 percent, 100 percent, and 115 percent, depending on the level of Medicare spending.
“[G]iven the size and scope of these cuts, Medicare beneficiaries are likely to face higher costs and coverage disruptions in the coming years,” AHIP said.
Shortly after passage, the CMS Office of the Actuary said the law would reduce funding for MA by $145 billion over 10 years and enrollment by 50 percent once the cuts are fully phased in. The Congressional Budget Office estimated the 10-year reduction at $134.9 billion and that enrollment would be reduced to 9.1 million in 2019, rather than the 13.9 million that had been estimated without the new formula.
Asked about the enrollment estimations of CBO and the Office of the Actuary, Blum said that, although he respected the two offices, their predictions thus far have not proven true.
Blum credited increases in enrollment to a competitive marketplace and CMS's management of the program. He added that the average number of MA plans beneficiaries will have to choose from will increase from 26 to 28 in 2013.
Danielle R. Moon, director of CMS's Medicare Drug & Health Plan Contract Administration Group, said in a later briefing that in 2013, 1.3 percent of enrollees will lose their plans due to nonrenewals--424,000 in 2013, compared with 321,000 in 2012. This represents 3 percent of MA enrollees and 0.1 percent of enrollees in stand-alone plans, she said.
However, only 2,400 beneficiaries will lack access to an alternative, she said.
Quality ratings on CMS's one-to-five-star system will be posted on Oct. 11, Blum said.
Although he did not say whether the number of five-star plans would increase, Blum said there would be a “very positive change” in average scores.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)